109 related articles for article (PubMed ID: 23737157)
1. Cross-talk between the ligand- and DNA-binding domains of estrogen receptor.
Huang W; Greene GL; Ravikumar KM; Yang S
Proteins; 2013 Nov; 81(11):1900-9. PubMed ID: 23737157
[TBL] [Abstract][Full Text] [Related]
2. Conformational dynamics of the estrogen receptor alpha: molecular dynamics simulations of the influence of binding site structure on protein dynamics.
Celik L; Lund JD; Schiøtt B
Biochemistry; 2007 Feb; 46(7):1743-58. PubMed ID: 17249692
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor α L543A,L544A mutation changes antagonists to agonists, correlating with the ligand binding domain dimerization associated with DNA binding activity.
Arao Y; Hamilton KJ; Coons LA; Korach KS
J Biol Chem; 2013 Jul; 288(29):21105-21116. PubMed ID: 23733188
[TBL] [Abstract][Full Text] [Related]
4. Multidomain architecture of estrogen receptor reveals interfacial cross-talk between its DNA-binding and ligand-binding domains.
Huang W; Peng Y; Kiselar J; Zhao X; Albaqami A; Mendez D; Chen Y; Chakravarthy S; Gupta S; Ralston C; Kao HY; Chance MR; Yang S
Nat Commun; 2018 Aug; 9(1):3520. PubMed ID: 30166540
[TBL] [Abstract][Full Text] [Related]
5. Low-resolution structures of thyroid hormone receptor dimers and tetramers in solution.
Figueira AC; Neto Mde O; Bernardes A; Dias SM; Craievich AF; Baxter JD; Webb P; Polikarpov I
Biochemistry; 2007 Feb; 46(5):1273-83. PubMed ID: 17260956
[TBL] [Abstract][Full Text] [Related]
6. Role of aspartate 351 in transactivation and active conformation of estrogen receptor alpha.
Kim JH; Lee MH; Kim BJ; Kim JH; Han SJ; Kim HY; Stallcup MR
J Mol Endocrinol; 2005 Dec; 35(3):449-64. PubMed ID: 16326832
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of GATA2-dependent transactivation of the TSHbeta gene by ligand-bound estrogen receptor alpha.
Nagayama K; Sasaki S; Matsushita A; Ohba K; Iwaki H; Matsunaga H; Suzuki S; Misawa H; Ishizuka K; Oki Y; Noh JY; Nakamura H
J Endocrinol; 2008 Oct; 199(1):113-25. PubMed ID: 18653622
[TBL] [Abstract][Full Text] [Related]
8. Activation helix orientation of the estrogen receptor is mediated by receptor dimerization: evidence from molecular dynamics simulations.
Fratev F
Phys Chem Chem Phys; 2015 May; 17(20):13403-20. PubMed ID: 25927714
[TBL] [Abstract][Full Text] [Related]
9. In silico identification of novel inhibitors targeting the DNA-binding domain of the human estrogen receptor alpha.
Cao H; Sun Y; Wang L; Pan Y; Li Z; Liang Y
J Steroid Biochem Mol Biol; 2021 Oct; 213():105966. PubMed ID: 34416373
[TBL] [Abstract][Full Text] [Related]
10. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
[TBL] [Abstract][Full Text] [Related]
11. Structural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor function.
Nascimento AS; Dias SM; Nunes FM; Aparício R; Ambrosio AL; Bleicher L; Figueira AC; Santos MA; de Oliveira Neto M; Fischer H; Togashi M; Craievich AF; Garratt RC; Baxter JD; Webb P; Polikarpov I
J Mol Biol; 2006 Jul; 360(3):586-98. PubMed ID: 16781732
[TBL] [Abstract][Full Text] [Related]
12. Molecular dynamics simulation in solvent of the estrogen receptor protein DNA binding domain in complex with a non-consensus estrogen response element DNA sequence.
Harris LF; Sullivan MR; Popken-Harris PD
J Biomol Struct Dyn; 1997 Dec; 15(3):407-30. PubMed ID: 9439992
[TBL] [Abstract][Full Text] [Related]
13. Conformational dynamics and molecular recognition: backbone dynamics of the estrogen receptor DNA-binding domain.
Wikström A; Berglund H; Hambraeus C; van den Berg S; Härd T
J Mol Biol; 1999 Jun; 289(4):963-79. PubMed ID: 10369775
[TBL] [Abstract][Full Text] [Related]
14. Structural insights into Resveratrol's antagonist and partial agonist actions on estrogen receptor alpha.
Chakraborty S; Levenson AS; Biswas PK
BMC Struct Biol; 2013 Oct; 13():27. PubMed ID: 24160181
[TBL] [Abstract][Full Text] [Related]
15. Small-angle X-ray scattering studies on structures of an estrogen-related receptor alpha ligand binding domain and its complexes with ligands and coactivators.
Jin KS; Park JK; Yoon J; Rho Y; Kim JH; Kim EE; Ree M
J Phys Chem B; 2008 Aug; 112(32):9603-12. PubMed ID: 18646811
[TBL] [Abstract][Full Text] [Related]
16. New computational strategy to analyze the interactions of ERalpha and ERbeta with different ERE sequences.
Marabotti A; Colonna G; Facchiano A
J Comput Chem; 2007 Apr; 28(6):1031-41. PubMed ID: 17269124
[TBL] [Abstract][Full Text] [Related]
17.
Bouricha EM; Hakmi M; Akachar J; Zouaidia F; Ibrahimi A
J Biomol Struct Dyn; 2022 Jul; 40(11):5203-5210. PubMed ID: 33402049
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity.
Solomon IH; Hager JM; Safi R; McDonnell DP; Redinbo MR; Ortlund EA
J Mol Biol; 2005 Dec; 354(5):1091-102. PubMed ID: 16289203
[TBL] [Abstract][Full Text] [Related]
19. Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor.
Doesburg P; Kuil CW; Berrevoets CA; Steketee K; Faber PW; Mulder E; Brinkmann AO; Trapman J
Biochemistry; 1997 Feb; 36(5):1052-64. PubMed ID: 9033395
[TBL] [Abstract][Full Text] [Related]
20. Use of binding energy in comparative molecular field analysis of isoform selective estrogen receptor ligands.
Wolohan P; Reichert DE
J Mol Graph Model; 2004 Sep; 23(1):23-38. PubMed ID: 15331051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
